Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16690067rdf:typepubmed:Citationlld:pubmed
pubmed-article:16690067lifeskim:mentionsumls-concept:C0302908lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C0008428lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C0683150lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:16690067lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:16690067pubmed:issue1-2lld:pubmed
pubmed-article:16690067pubmed:dateCreated2006-7-10lld:pubmed
pubmed-article:16690067pubmed:abstractTextA simple and reliable HPLC method for the determination of the plasma level of K-27, an oxime type antidote of use in organophosphorus poisoning is presented. Separation was carried out by HPLC using an octyl silica stationary phase and a mobile phase consisting of 93% phosphate buffer (pH 2.6) containing octane sulfate sodium salt, and 7% methanol. Quantitative absorbance was monitored at 286 nm. The calibration curve was linear through the range of 1.25-200 microg/mL, that is well beyond the detected plasma level range of K-27. Limit of quantitation was 5 microg/mL. Intra-day and inter-day precisions of the HPLC determinations gave standard deviations as 0.77 and 2.67%, respectively. Following intramuscular administration of 50 micromol (22.31 mg) K-27 in rats, the maximum of K-27 concentration in plasma was reached at about 15 min giving 186 microg/mL and the t(1/2) was 85 min. K-27 displays initial (from 15 trough 120 min) zero order elimination kinetics. Similar results have been found after intraperitoneal administration.lld:pubmed
pubmed-article:16690067pubmed:languageenglld:pubmed
pubmed-article:16690067pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690067pubmed:citationSubsetIMlld:pubmed
pubmed-article:16690067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690067pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16690067pubmed:statusMEDLINElld:pubmed
pubmed-article:16690067pubmed:monthJullld:pubmed
pubmed-article:16690067pubmed:issn0021-9673lld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:TekesKKlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:PetroianuGGlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:HasanM YMYlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:KalászHHlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:SheenRRlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:KucaKKlld:pubmed
pubmed-article:16690067pubmed:authorpubmed-author:LudányiKKlld:pubmed
pubmed-article:16690067pubmed:issnTypePrintlld:pubmed
pubmed-article:16690067pubmed:day28lld:pubmed
pubmed-article:16690067pubmed:volume1122lld:pubmed
pubmed-article:16690067pubmed:ownerNLMlld:pubmed
pubmed-article:16690067pubmed:authorsCompleteYlld:pubmed
pubmed-article:16690067pubmed:pagination84-7lld:pubmed
pubmed-article:16690067pubmed:dateRevised2009-1-15lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:meshHeadingpubmed-meshheading:16690067...lld:pubmed
pubmed-article:16690067pubmed:year2006lld:pubmed
pubmed-article:16690067pubmed:articleTitleHigh-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.lld:pubmed
pubmed-article:16690067pubmed:affiliationDepartment of Pharmacodynamics, Semmelweis University, Budapest, Hungary.lld:pubmed
pubmed-article:16690067pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16690067pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed